Objective: Ischemic injury of axons is a feature of periventricular leukomalacia, a pathological correlate of cerebral palsy. Recent evidence suggests that axons are damaged before they receive the first layer of compact myelin. We here examine the cellular mechanisms underlying ischemic-type injury of premyelinated central axons.
Methods: Two thirds of axons in the post-natal day 10 rat optic nerve are small premyelinated axons (<0.4 µm diameter), and one third have undergone radial expansion in preparation for glial contact and the onset of myelination. Compound action potential recording and quantitative electron microscopy were used to examine the effect of modelled ischemia (oxygen-glucose deprivation) upon these two axon populations.
Glutamate receptor expression was investigated using PCR and immuno-staining approaches at the confocal light and ultrastructural levels.
Results: Oxygen-glucose deprivation produced action potential failure and focal breakdown of the axolemma of small premyelinated axons at sites of contact with oligodendrocyte processes, which were also disrupted. The resulting axon loss was Ca 2+ -dependent, Na + -and Cl --independent and required activation of NMDA and non-NMDA glutamate receptors. NMDA receptor expression was localized to oligodendrocyte processes at sites of contact with premyelinated axons, in addition to expression within compact myelin. No peri-axonal NMDA receptor expression was observed on oligodendrocyte processes ensheathing large premyelinated axons and no protective effect of glutamate receptor block was observed in these axons.
Interpretation: NMDA receptor-mediated injury to oligodendrocyte processes navigating along small premyelinated axons precedes damage to the underlying axon, a phenomena that is lost following radial expansion and subsequent oligodendrocyte ensheathment. 
Introduction
Selective injury of developing white matter is the most frequent cause of cerebral palsy, the most common human birth disorder. The underlying pathology (periventricular leukomalacia: PVL), may feature focal necrotic damage of periventricular white matter and diffuse white matter injury. White matter injury may arise following hypoxiaischemia at birth, but the largest patient cohort suffer injury during mid-gestation 1, 2 . The motor, sensory and cognitive deficits that characterize the lesion are associated with injury to immature cells of the oligodendroglial lineage, which are susceptible to a form of non-NMDA-type glutamate receptor (GluR) -mediated excitotoxic injury [3] [4] [5] [6] [7] [8] . In addition to non-NMDA receptors, these cells express NMDA GluRs selectively on their processes [9] [10] [11] , although the role of NMDA receptors in ischemic injury of myelinated white matter is controversial [12] [13] [14] [15] .
Oligodendroglial injury has been the focus of research into the cellular mechanisms of developing white matter injury for the past decade. However, axon damage is consistently reported in histological examinations of PVL 2, 16, 17 . Axonal changes include truncation of the axon cylinder 18 and the formation of "retraction balls and clubs" 16 . Recent reports indicate that axonal injury is an early event in the formation of both focal and diffuse components of PVL [19] [20] [21] , and may be central to the evolution of the injury 17 . Despite these considerations, almost nothing is known regarding the injury mechanisms operating upon premyelinated central axons. In mid-gestation telencephalic white matter that is subject to PVL, axons have an immature expression profile for developmental markers and oligodendroglia are changing from the precursor to the immature form 22, 23 . The first evidence of early myelination is apparent, which includes myelin basic protein expression around some axons of the optic radiation 23 . There is evidence that injury to these axons during PVL can result in optic nerve hypoplasia 24 .
Central axon development has been studied in detail in the rat optic nerve (RON), where radial expansion corresponding to an ~3 fold increase in diameter within an ~4 day period precedes first contact by oligodendrocyte processes and the subsequent onset of myelination 25 . The first post-mitotic oligodendrocytes appear at post-natal day 6 (P6) and start to extend processes parallel to axons [26] [27] [28] . The first ensheathed axons appear at this Deleted: clubs" 16 . Recent reports indicate that axonal injury is an early event in the formation of both focal and diffuse components of PVL [19] [20] [21] , and may be central to the evolution of the injury 17 . Despite these considerations, almost nothing is known regarding the injury mechanisms operating upon premyelinated central axons. In midgestation telencephalic and periatal white matter that is subject to PVL, axons have an immature expression profile for developmental markers and oligodendroglia are changing from the precursor to the immature form F o r P e e r R e v i e w 4 age and correspond to the largest premyelinated axons with diameters of >=0. 4 Bioscience, see 10 for further details), and imaged as single planes via laser scanning confocal microscopy. Primary antibody omission controls were performed and are included in the figures at appropriate points. Intensity levels of neurofilament staining
were assessed using mean pixel intensity levels within standard regions of interest, performed using Metamorph (Universal Imaging).
For PCR, P10 RONs were digested in MELT (Ambion) and subjected to a triazol extraction. RNA was then column purified and the resulting RNA treated to remove DNA contamination. The RNA was purified by extraction with phenol, pH 4.2, (Sigma) and resuspended to a concentration of 1µg/µl. PCR was then performed using Omniscript (Qiagen) according to the manufacturer's instructions. All primers were tested on whole brain as a positive control, see 10 for further details.
For electron-microscopy, P10 RONs were collected at the end of electrophysiological experiments, washed in Sorenson's buffer and post-fixed in 3%
gluteraldehyde/Sorenson's. Nerves were then fixed with 2% osmium tetroxide and For morphometric analysis and viability scoring, axons within a minimum of three grid sections were outlined by hand using Image-J software (NIH) and axon area and perimeter were measured. Grids were selected at random and all identifiable axons within the area were included to avoid bias. Axon profiles were often far from round and the closest corresponding circular diameter was calculated from the perimeter values.
Axon viability scores were assigned blind using the following scoring system. Axons ; Fig 1 a-c) , an effect confirmed at the ultrastructural level (Fig 2 d) . Staining for the axonal markers NF-L and NF-H, which label small diameter and larger diameter axons respectively 31 , was also disrupted in axons following 60 min of OGD + 60 min recovery (Fig 1 e, f) . Confocal imaging of post-OGD staining revealed areas denuded of neurofilament reactivity and ball-like structures that may correspond to swollen axon regions. Staining levels were quantified to reveal a similar decline in reactivity to NF-L and NH-H following the insult (Fig 1 f) . by a narrow extracellular space and by glial processes (Fig 2 a "S" and "L" premyelinated axons respectively), with the occasional myelinated axon apparent (Fig 2 a "Ax") . Some of the large premyelinated axons were ensheathed by glial processes (Fig 2 a , "*"), shown in long-section in Fig 2 c (arrow) . Mitochondria in all cell compartments had a typical internal structure and showed no evidence of swelling. Following OGD, the extracellular space was expanded and nondescript cellular debris was common (Fig 2 b) . Many premyelinated axons showed a loss of microtubules and regions of axolemma breakdown (Fig 2 b) , and extensive disruption of glial processes was widespread (intact glial processes were only occasionally seen). In long section, regions of intense focal premyelinated axon disruption were seen (Fig 2 e , "Axon" arrow heads), generally aligned parallel to damaged regions of neighbouring glial processes ("gp" arrow heads).
Identification of axons in post OGD micrographs was based upon the presence of , replacing extracellular Na + (Fig 3 a-c; supplemental Fig 2) or Cl - (Fig 3 d-f ) was not protective against injury. This was not due to any toxicity of ion substitution at this age since control ion substitutions had no significant non-reversible effect (Fig 3 a, c, d, f) . This result suggests a fundamentally different ionic basis to injury in premyelinated and myelinated axons, and rules out a significant role for Na-Ca exchange or Cl -channels in the injury process 33, 34 . In particular, Na + replacement leads to rapid depletion of axoplasmic Na + and block of reverse-mode Na-Ca exchange, a major source of Ca 2+ influx in mature myelinated axons during anoxia
33
. The finding was confirmed at the ultrastructural level where wide-scale disruption of axons following OGD in zero-Na + conditions was confirmed (supplemental expression was similar in P10 RON to that reported in the P10 mouse optic nerve 10 .
Confocal imaging indicated that NR1 subunit protein is colocalized with CNPase (+) oligodendroglial processes but not with N-FH (+) axon profiles (Fig 6 a, b ). GluR4
protein (non-NMDA subunit) appeared primarily in CNPase (+) oligodendroglial somata (Supplemental Fig 3) . At the ultrastructural level, intense NR1 protein reactivity was found in regions where oligodendrocyte process membrane ran parallel to the axolemma of small premyelinated axons, in addition to expression within compact myelin as previously reported 9,11 (Fig 6 e-g arrows, supplemental Figs 4, 5) . NR1 reactivity appeared to translocate from the axolemmal face of oligodendrocyte processes aligned along small diameter premyelinated axons into the myelin as development progressed.
On no occasion was NR1 reactivity seen in the cell membrane of axons or astrocytes and it was unusual to see it in cell membranes of oligodendroglial somata. Perfusion with AMPA+kainate produced a small but significant fall in the CAP (Fig 7 a) , which achieved higher significance in the presence of the AMPA desensitization inhibitor cyclothiazide. Addition of NMDA to the test condition did not produce any significant augmentation of this effect (Fig 7 b " all agonists"). Immunolocalization using an antibody against the AMPA receptor Glur2/3 subunit revealed high expression in and under myelin and in the axolemma of premyelinated axons (Fig 7 c-e ).
The kainate receptor KA2 subunit showed more focal expression at sites within and under myelin, in addition to the axolemma of premyelinated axons (Fig 7 f-i ). , with clusters of NR1 NMDA subunit protein reactivity colocalized with CNPase (+) oligodendroglial processes but not with N-FH (+) axon profiles (Fig 6 a, b Possible mediators that might link NMDA receptor-mediated oligodendrocyte process injury with axon injury include local release of intracellular potassium resulting in axon depolarization and cytotoxic swelling; physical disruption of the axolemma during oligodendrocyte process swelling and dissolution, which will also disrupt the extracellular matrix; release of free radicals; and release of intracellular components such as calpains and lipases that are likely to attack the axon directly.
In addition to expression on oligodendrocyte processes, NMDA receptors were found in early compact myelin. Similar myelin expression in mature RON can mediate cytotoxic Ca 2+ influx [9] [10] [11] . As a result, NMDA receptors contribute to OGD-induced injury in this preparation 12 , although apparently not in mouse optic nerve 14, 15 , and vesicular-and transporter-mediated glutamate release are potential sources of the extracellular glutamate responsible for GluR-mediated injury of oligodendrocyte processes described in the current study. Astrocytes may also act as a source of ischemic glutamate release in developing white matter 37, 38 . The localization of NMDA receptors to oligodendrocyte processes aligned along the axolemma of premyelinated axons indicates that Ca 2+ -dependent, Na + -and Cl --independent, injury to the processes at these sites precedes breakdown of the neighbouring axolemma. The findings therefore place oligodendrocyte process injury before premyelinated axon injury Deleted: . Premyelinated central axons also express functional glutamate transporters 37 , and vesicular-and transporter-mediated glutamate release are potential sources of the extracellular glutamate responsible for GluR-mediated injury of oligodendrocyte processes described in the current study. Astrocytes may also act as a source of ischemic glutamate release in developing white matter 37, 38 . The localization of NMDA receptors to oligodendrocyte processes aligned along the axolemma of premyelinated axons indicates that Ca 2+ -dependent, Na + -and Cl --independent, injury to the processes at these sites precedes breakdown of the neighbouring axolemma. The findings therefore place oligodendrocyte process injury before premyelinated axon injury in the sequence of events that result in acute loss of function in early developing white matter during ischemia. ¶ In addition to expression on oligodendrocyte processes aligned along premyelinated axons, NMDA receptor protein was also observed in early compact myelin. Similar expression in myelin is seen in mature rat optic nerve where it can mediate cytotoxic Ca 2+ influx [9] [10] [11] . Presumably as a result, NMDA receptors contribute to ischemic injury in myelinated rat optic nerve 12 , although no similar effect is found in mouse optic nerve 14, 15 . The current findings indicate ... [1] ... . "*" = P<0.05; "***" = P<0.001. Scale bars = 1 µm in "e", 400 nm in "f", 100 nm in "g". labelling. e: A small diameter pre-myelinated axon ("s") is aligned between an astrocyte process ("ap") and two myelinated axons ("Ax"). The boxed region is shown at higher gain to the right. Three immuno-gold beads (short arrows) are present on the junction between an oligodendroglial process ("op") and the small premyelinated axon. Note the absence of NR1 reactivity on the astrocyte process. Also note the tubulovesicular complex apparently fusing with the axolemma at this point ("*"), and the NR1 reactivity within the compact myelin of a neighbouring axon (short arrow). f: An oligodendrocyte somata ("Oli") is extending a process showing NR1 reactivity (short arrows) along a small pre-myelinated axon. Note that no reactivity is seen in the somata itself. The boxed area is shown at higher gain to the right and reveals NR1 reactivity on the outer edge of an actively myelinating oligodendrocyte process. g: Two oligodendrocyte processes (boxes) are navigating along small pre-myelinated axons (shown in great detail to the right). In both cases, NR1 reactivity is present on the axon side of the process. "gp"
indicates that this glial process can not be positively identified as an oligodendrocyte process. Scale bars = a-c: 10 µm; e-f = 500 nm. were used for the histogram data). Cyclothiazide has no effect applied alone. c-i:
Localization of GluR 2/3 (c-e) and KA2 (f-i) subunit at the ultrastructural level by Supplementary Figure 4 Immuno-electron micrograph showing NR1 reactivity in P10 RON. One contiguous oligodendrocyte process ("op") expressed NR1 reactivity at several sites that are close to small diameter premyelinated axons ("S"), including within extensions that appear to be navigating along small axons (arrows).
Supplementary Figure 5 Immuno-electron micrographs showing NR1 reactivity in early compact myelin in P10
RON. Note that reactivity is present either within the myelin itself or on the outer surface as layers are being added. Scale bars = 500 nm.
Deleted: axons. , and vesicular-and transportermediated glutamate release are potential sources of the extracellular glutamate responsible for GluR-mediated injury of oligodendrocyte processes described in the current study. Astrocytes may also act as a source of ischemic glutamate release in developing white matter 37, 38 . The localization of NMDA receptors to oligodendrocyte processes aligned along the axolemma of premyelinated axons indicates that Ca 2+ -dependent, Na + -and Cl --independent, injury to the processes at these sites precedes breakdown of the neighbouring axolemma. The findings therefore place oligodendrocyte process injury before premyelinated axon injury in the sequence of events that result in acute loss of function in early developing white matter during ischemia.
In addition to expression on oligodendrocyte processes aligned along premyelinated axons, NMDA receptor protein was also observed in early compact myelin. Similar expression in myelin is seen in mature rat optic nerve where it can mediate cytotoxic Ca 2+ influx [9] [10] [11] . Presumably as a result, NMDA receptors contribute to ischemic injury in myelinated rat optic nerve 12 , although no similar effect is found in mouse optic nerve 14, 15 . . The mechanism of small premyelinated axon injury following GluRmediated disintegration of neighbouring oligodendrocyte process will be difficult to dissect from the process injury itself. Possible mediators include local release of intracellular potassium onto the axolemma resulting in depolarization and cytotoxic swelling; physical disruption of the axolemma during oligodendrocyte process swelling and dissolution, which will also disrupt the extracellular matrix; release of free radicals capable of damaging the axolemma; and release of intracellular components such as calpains and lipases likely to attack the axon directly.
In addition to NMDA GluRs on their processes, developing oligodendroglia express non-NMDA receptors that can mediate toxic Ca 2+ -influx during ischemic conditions [3] [4] [5] [6] [7] . The current findings support the view that these receptors are expressed mainly on the somata 10 . Block of either NMDA or non-NMDA GluRs provided a similar degree of protection from ischemic conditions. This may reflect the significant degree of In addition to expression on oligodendrocyte processes aligned along premyelinated axons, NMDA receptor protein was also observed in early compact myelin. Similar expression in myelin is seen in mature rat optic nerve where it can [9] [10] [11] . Presumably as a result, NMDA receptors contribute to ischemic injury in myelinated rat optic nerve 12 , although no similar effect is found in mouse optic nerve 14, 15 . . The mechanism of small premyelinated axon injury following GluRmediated disintegration of neighbouring oligodendrocyte process will be difficult to dissect from the process injury itself. Possible mediators include local release of intracellular potassium onto the axolemma resulting in depolarization and cytotoxic swelling; physical disruption of the axolemma during oligodendrocyte process swelling and dissolution, which will also disrupt the extracellular matrix; release of free radicals capable of damaging the axolemma; and release of intracellular components such as calpains and lipases likely to attack the axon directly.
In addition to NMDA GluRs on their processes, developing oligodendroglia express non-NMDA receptors that can mediate toxic Ca 2+ -influx during ischemic conditions [3] [4] [5] [6] [7] . The current findings support the view that these receptors are expressed mainly on the somata 10 . Block of either NMDA or non-NMDA GluRs provided a similar degree of protection from ischemic conditions. This may reflect the significant degree of The extent of recovery following these procedures. e, f: Small diameter premyelinated axons ("S") and oligodendrocyte processes ("op") are protected from OGD in the presence of MK-801 + NBQX, while larger axons ("L") are not. g: A large diameter premyelinated axon has no axoplasmic structures intact while a glial process wrapped around the axon is undamaged (arrow heads). "*" = P<0.05; "***" = P<0.001. Scale bars = 1 µm in "e", 400 nm in "f", 100 nm in "g".
88x155mm (600 x 600 DPI) GluRs in developing white matter. a: NR1 (green, left) and CNPase (red, middle) appear to be colocalized (right) using fluorescent confocal imaging. Note that the NR1 clusters appear orange in the overlay. b: NR1 (green, left) and NF-H (red, middle) appear poorly co-localized (right). Note that the NR1 clusters appear green in the overlay. c: Absence of staining when NR1 antibody was omitted. d: mRNA for NMDA receptor subunits in P10 RON. e-g: Localization of GluR NR1 subunit at the ultrastructural level by immuno-gold labelling. e: A small diameter pre-myelinated axon ("s") is aligned between an astrocyte process ("ap") and two myelinated axons ("Ax"). The boxed region is shown at higher gain to the right. Three immuno-gold beads (short arrows) are present on the junction between an oligodendroglial process ("op") and the small premyelinated axon. Note the absence of NR1 reactivity on the astrocyte process. Also note the tubulovesicular complex apparently fusing with the axolemma at this point ("*"), and the NR1 reactivity within the compact myelin of a neighbouring axon (short arrow). f: An oligodendrocyte somata ("Oli") is extending a process showing NR1 reactivity (short arrows) along a small pre-myelinated axon. Note that no reactivity is seen in the somata itself. The boxed area is shown at higher gain to the right and reveals NR1 reactivity on the outer edge of an actively myelinating oligodendrocyte process. g: Two oligodendrocyte processes (boxes) are navigating along small pre-myelinated axons (shown in great detail to the right). In both cases, NR1 reactivity is present on the axon side of the process. "gp" indicates that this glial process can not be positively identified as an oligodendrocyte process. Scale bars = a-c: 10 µm; e-f = 500 nm. 1 mM NMDA + 50 µM glycine in the absence of Mg2+ also produced a small reversible fall in CAP amplitude (*** = P<0.01 vs. control; 'n' numbers as indicated; times "1" and "3" were used for the histogram data). Cyclothiazide has no effect applied alone. c-i: Localization of GluR 2/3 (c-e) and KA2 (f-i) subunit at the ultrastructural level by immuno-gold labelling. c: Strong staining (short arrows) is apparent for GluR 2/3 in a myelinating axon ("Ax"), with gold particles present within and under the myelin ("my"). The axon contains a mitochondria ("mit"). Staining is also present on the axoplasmic side of the axolemma (the axolemma is indicated by arrow heads) of a neighbouring small premyelinated axon ("s"). d: Gold particles largely located on the axoplasmic side of the myelin of a myelinating axon. e: Three gold particles are located on the interface between a glial processe ("gp") and a small pre-myelinated axon (axolemma indicated by arrowheads). f: Immunolabelling for KA-2 reveals focal expression associated with the myelin of an actively myelinating axon. g: Focal axolemma staining of a premyelinated axon facing an ensheathing oligodendrocyte process ("op"). h: focal staining on the axolemma underneath an actively myelinating oligodendrocyte process. Note the near-by astrocyte processes ("ap"). i: KA-2 reactivity in the axoplasm and axolemma of small premyelinating axons contacted by glial processes. Scale = 500 
